JPS5846023A - ヒトプロインシユリン製剤 - Google Patents

ヒトプロインシユリン製剤

Info

Publication number
JPS5846023A
JPS5846023A JP57148493A JP14849382A JPS5846023A JP S5846023 A JPS5846023 A JP S5846023A JP 57148493 A JP57148493 A JP 57148493A JP 14849382 A JP14849382 A JP 14849382A JP S5846023 A JPS5846023 A JP S5846023A
Authority
JP
Japan
Prior art keywords
proinsulin
human
human proinsulin
insulin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57148493A
Other languages
English (en)
Japanese (ja)
Inventor
ロナルド・イ−・チヤンス
ブル−ス・エイチ・フランク
ジヨ−ン・エイ・ガロウエイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS5846023A publication Critical patent/JPS5846023A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP57148493A 1981-08-27 1982-08-25 ヒトプロインシユリン製剤 Pending JPS5846023A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29675281A 1981-08-27 1981-08-27
US296752 1981-08-27

Publications (1)

Publication Number Publication Date
JPS5846023A true JPS5846023A (ja) 1983-03-17

Family

ID=23143402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57148493A Pending JPS5846023A (ja) 1981-08-27 1982-08-25 ヒトプロインシユリン製剤

Country Status (21)

Country Link
JP (1) JPS5846023A (hu)
AU (1) AU552054B2 (hu)
BE (1) BE894186A (hu)
CA (1) CA1176160A (hu)
CH (1) CH650677A5 (hu)
DE (1) DE3232036A1 (hu)
FR (1) FR2511866B1 (hu)
GB (1) GB2104380B (hu)
HU (1) HU193522B (hu)
IE (1) IE53829B1 (hu)
IL (1) IL66610A (hu)
IT (1) IT1153184B (hu)
LU (1) LU84358A1 (hu)
MW (1) MW3782A1 (hu)
MY (1) MY8700757A (hu)
NL (1) NL8203316A (hu)
NZ (1) NZ201683A (hu)
PH (1) PH18716A (hu)
SE (1) SE8204871L (hu)
ZA (1) ZA826157B (hu)
ZW (1) ZW17382A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
EP0166971B1 (de) * 1984-06-09 1990-02-28 Hoechst Aktiengesellschaft Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
USD1010056S1 (en) * 2020-08-25 2024-01-02 Magpul Industries Corp. Gun sight

Also Published As

Publication number Publication date
HU193522B (en) 1987-10-28
LU84358A1 (fr) 1983-02-28
ZW17382A1 (en) 1982-11-17
IL66610A0 (en) 1982-12-31
IE53829B1 (en) 1989-03-15
FR2511866A1 (fr) 1983-03-04
GB2104380B (en) 1984-12-05
PH18716A (hu) 1985-09-11
ZA826157B (en) 1984-04-25
NL8203316A (nl) 1983-03-16
IL66610A (en) 1985-11-29
FR2511866B1 (fr) 1986-08-14
AU8759582A (en) 1983-03-03
BE894186A (fr) 1983-02-24
IT1153184B (it) 1987-01-14
IT8223019A0 (it) 1982-08-27
MW3782A1 (en) 1984-06-13
IE822062L (en) 1983-02-27
SE8204871D0 (sv) 1982-08-25
MY8700757A (en) 1987-12-31
CA1176160A (en) 1984-10-16
NZ201683A (en) 1985-08-16
CH650677A5 (de) 1985-08-15
AU552054B2 (en) 1986-05-22
SE8204871L (sv) 1983-02-28
DE3232036A1 (de) 1983-03-10
GB2104380A (en) 1983-03-09

Similar Documents

Publication Publication Date Title
CN101287457B (zh) Treprostinil用于治疗神经性糖尿病的足部溃疡的用途
DE69631544T2 (de) Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
US7291594B2 (en) GLP-1 derivative and preparation thereof absorbable via mucous membrane
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
CA1176161A (en) Pharmaceutical formulations comprising human insulin and human proinsulin
CA1176158A (en) Pharmaceutical formulations comprising human insulin and human c-peptide
US4654324A (en) Human proinsulin pharmaceutical formulations
JPS5846023A (ja) ヒトプロインシユリン製剤
CA1176159A (en) Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin
KR20200130297A (ko) 비만의 치료 및 체중 관리를 위한 glp-1 조성물
JP7360751B2 (ja) FGF21 Fc融合タンパク質、GLP-1 Fc融合タンパク質、それらの併用治療剤および使用
US6303127B1 (en) Treatment of disease states
US6153581A (en) Drug for recovering renal function
WO1998041222A1 (en) Obesity protein formulations
AU711428B2 (en) Monomeric insulin analog formulations
JPS59175437A (ja) 高コレステロ−ル血症改善剤
JPH0827024A (ja) 口腔粘膜疾患治療剤
JPH08188538A (ja) ニューロレプト麻酔時の血圧調節剤